Nutrition support may prolong survival in high risk patients with gastric cancer
the ONA take:
According to a new study published in the journal Supportive Care in Cancer, researchers in China have found that nutrition support might be helpful to improve the prognosis of patients with stage IV gastric cancer whose Nutritional Risk Screening (NRS) score is 3 or higher.
For the study, researchers sought to evaluate whether nutrition support can extend survival of patients with advanced gastric cancer cancer.
Researchers prospectively evaluated the nutritional risk of 830 patients with gastric adenocarcinoma. Of those, 50.7% had an NRS ≥3. Then, patients with stage IV disease whose NRS was ≥3 were given nutrition support.
Results showed that NRS ≥3 was an independent adverse prognostic factor in patients with gastric cancer. Median survival was over 6 months longer in patients with an NRS <3.
In addition, among the 347 patients with an NRS ≥3 who were given nutrition support, those who were young, male, and achieved a good response to chemotherapy were more likely to shirt to NRS <3 after nutrition support.
Researchers found that median overall survival was 14.3 months for patients with the NRS shift compared with 9.6 months for those without the shift.
Nutrition support might be helpful to improve the prognosis of patients with stage IV gastric cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
- Pediatric Patients, Parents Overreport Adherence to ALL Medication Regimen
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|